The following is a summary of “High 11-ketotestosterone linked to shorter time to castration resistance in recurrent ...

Truqap combination showed a statistically and clinically meaningful improvement in radiographic progression-free survival for ...

Pathstone Holdings LLC grew its stake in ADT Inc. (NYSE:ADT – Free Report) by 3.6% during the third quarter, according to its ...

AstraZeneca has reported positive results from a Phase III trial that evaluated Truqap combined with abiraterone and ADT for ...

AstraZeneca (AZN) reported positive results from a Phase 3 study of its drug Truqap in the treatment of a certain type of ...

On Friday, ADT Inc (ADT) stock saw a modest uptick, ending the day at $7.54 which represents no change from the prior close of of $7.54. The stock opened at $7.57 and touched a low of $7.5 during the ...

Investigators explored the role of treatment intensification with androgen receptor pathway inhibitors in patients with high-risk localized prostate cancer.

Results from the CAPItello-281 Phase III trial showed that AstraZeneca’s (AZN) Truqap in combination with abiraterone and androgen deprivation ...

AstraZeneca PLC on Monday said its Truqap combination in a type of prostate cancer showed a statistically significant improvement in a form of progression-free survival. The Cambridge, England-based ...

British drug maker AstraZeneca Plc (AZN.L, AZN) announced Monday positive high-level results from CAPItello-281 Phase III trial of ...

The Mount Barker District Council initiated and funded inclusive dance project EveryBody Dance will have its red-carpet world ...

Our Top PicksBest Outdoor Wired Security CameraLorexLorex makes high quality security cameras and security camera systems — ...